Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)

Launched by UNIVERSITY HEALTH NETWORK, TORONTO · Aug 24, 2020

Keywords

ClinConnect Summary

This clinical trial, called the MC-RWE study, is looking at how medical cannabis can help people with conditions like pain, sleep issues, anxiety, depression, and epilepsy. The goal is to gather real-world evidence from patients who have been authorized to use medical cannabis. Participants will complete simple surveys to share how they feel before and after using cannabis, helping researchers understand its effectiveness.

To join the study, you need to be at least 19 years old and have a prescription for medical cannabis for one of the conditions mentioned. It's important that you either have never used cannabis before or have used it legally with a prescription. Participants will be asked to use only the approved medical cannabis products and avoid any recreational or illegal drugs during the study. If you join, you can expect to share your experiences regularly as part of the research, contributing valuable information about how medical cannabis can help others.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subjects (≥19 years of age) who are MC-naïve or -experienced with a medical authorization for MC provided by a prescribing health care practitioner and who have provided informed consent
• • Primary therapeutic indications for MC use: pain, epilepsy, sleep, and/or anxiety/depression.
• • Subjects agree to use verified products and refrain from using any other cannabis products, either medical or recreational, during the duration of the study
• Exclusion Criteria:
• • Concomitant use of illicit drugs
• • Concomitant use of recreational cannabis